Oct 9 |
Bio-Path Holdings Inc (BPTH) Q2 2024 Earnings Call Highlights: Financial Improvements and ...
|
Oct 9 |
Bio-Path announces $4M private placement
|
Oct 8 |
ACHR, BPTH, PLUG, REGRF:
|
Oct 8 |
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
|
Oct 8 |
Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity
|
Sep 16 |
Bio-Path Holdings Announces Publication in Biomedicines
|
Sep 4 |
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 24
|
Sep 3 |
Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
Aug 21 |
What Happened With Bio-Path Stock Today?
|
Aug 21 |
Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid Tumors
|